Keyword Connections

hr+/her2- metastatic breast cancer

Journals

1

1 Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Research Groups

0

No Research Group Connected

Bibliographies

3

1 Association of ADME gene polymorphisms on toxicity to CDK4/6 inhibitors in patients with HR+ HER2- metastatic breast cancer.

2 The PI3K/AKT/mTOR and CDK4/6 pathways in endocrine resistant HR+/HER2- metastatic breast cancer: Biological mechanisms and new treatments

3 Shared Decision-Making on Using a CDK4/6 Inhibitor plus an Aromatase Inhibitor for HR+/HER2- Metastatic Breast Cancer: A Podcast.